The US National Institutes of Health has fielded a lot of skepticism regarding the National Center for Advancing Translational Sciences. Many in the research and funding communities say drug discovery is best left to pharmaceutical and biotech companies and NIH should concentrate on its basic research mandate.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have an account?
Login Now.